Annals of Hematology最新文献

筛选
英文 中文
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-10 DOI: 10.1007/s00277-025-06236-x
Anna L Bode, Oscar F Borja-Montes, Mohammed A Quazi, Aqsa Mumtaz, Amir H Sohail, Christopher R Smith, Muhammad Rizwan Khawaja, Abu Baker Sheikh
{"title":"Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis.","authors":"Anna L Bode, Oscar F Borja-Montes, Mohammed A Quazi, Aqsa Mumtaz, Amir H Sohail, Christopher R Smith, Muhammad Rizwan Khawaja, Abu Baker Sheikh","doi":"10.1007/s00277-025-06236-x","DOIUrl":"https://doi.org/10.1007/s00277-025-06236-x","url":null,"abstract":"<p><p>Sickle cell disease (SCD) predominantly affects individuals of African descent and is characterized by frequent painful vaso-occlusive crises, often requiring opioid management. With the opioid epidemic raising concerns about opioid overdose, this study examines in-hospital outcomes among SCD and non-SCD patients hospitalized for opioid overdose. Using the National Inpatient Sample (NIS) from 2016 to 2021, we analyzed 479,175 opioid overdose hospitalizations, including 1,315 (0.3%) with a concomitant diagnosis of SCD. Propensity score matching was used to balance demographics, comorbidities, and hospital characteristics. SCD patients were younger (45.3% aged 30-49 vs. 33.1%, p < 0.001), predominantly of African descent (92.1% vs. 14.1%, p < 0.001), and more often from lower-income households (58.4% vs. 35.2%, p < 0.001). SCD patients had lower rates of mechanical ventilation (aOR: 0.7, 95% CI: 0.6-0.9) and anoxic brain injury (aOR: 0.5, 95% CI: 0.4-0.8) but experienced longer hospital stays and higher costs. No significant differences in in-hospital mortality were observed (aOR: 0.89, 95% CI: 0.7-1.1, p = 0.34). These findings emphasize the need for a nuanced approach to managing SCD patients during opioid overdose hospitalizations, focusing on mitigating complications, addressing prolonged hospital stays and higher costs, and reducing healthcare disparities through tailored strategies informed by the unique needs of this population.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143596046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a case report.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-08 DOI: 10.1007/s00277-025-06238-9
Géssika B G M Gutierrez de Moraes Pereira, Victor A Rocha, Paulo Victor R Barbosa, Christopher Cralcev, Alice V de Jesus, Mariana B Spadoni, Teresa Vilela V Pereira, João Paulo C Magalhães, Gislaine O Duarte, Guilherme Duffles, Felipe S Maia, Fernanda Surita, José Paulo S Guida, Carmino Antonio de Souza, Maria Laura Costa, Katia B B Pagnano
{"title":"Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a case report.","authors":"Géssika B G M Gutierrez de Moraes Pereira, Victor A Rocha, Paulo Victor R Barbosa, Christopher Cralcev, Alice V de Jesus, Mariana B Spadoni, Teresa Vilela V Pereira, João Paulo C Magalhães, Gislaine O Duarte, Guilherme Duffles, Felipe S Maia, Fernanda Surita, José Paulo S Guida, Carmino Antonio de Souza, Maria Laura Costa, Katia B B Pagnano","doi":"10.1007/s00277-025-06238-9","DOIUrl":"https://doi.org/10.1007/s00277-025-06238-9","url":null,"abstract":"<p><p>Managing chronic myeloid leukemia during pregnancy presents significant challenges, with limited treatment options available depending on the stage of pregnancy. All existing tyrosine kinase inhibitors are considered teratogenic, especially during the first trimester and should be avoided. In this case report, we detail the successful, unplanned dichorionic diamniotic twin pregnancy of a patient with chronic-phase myeloid leukemia previously resistant to imatinib and dasatinib who was exposed to the allosteric tyrosine kinase inhibitor asciminib during the early weeks of gestation. Upon confirmation of the pregnancy, asciminib was discontinued, and the patient was treated with pegylated interferon. The patient developed preeclampsia, and the twins were delivered prematurely via cesarean section. No other abnormalities were observed in the newborns. During her pregnancy, the patient experienced a loss of the major molecular response; however, she regained it within two months of resuming asciminib after giving birth. To our knowledge, this case represents the first report of a twin pregnancy during asciminib treatment.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143584456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-06 DOI: 10.1007/s00277-025-06257-6
Mahmoud I Elbadry, Elsayed Abdelkreem, Ahmed Tawfeek, Go Hun Seo, Shereen Philip Aziz
{"title":"Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility.","authors":"Mahmoud I Elbadry, Elsayed Abdelkreem, Ahmed Tawfeek, Go Hun Seo, Shereen Philip Aziz","doi":"10.1007/s00277-025-06257-6","DOIUrl":"https://doi.org/10.1007/s00277-025-06257-6","url":null,"abstract":"<p><p>This study investigates the burden, phenotypes, progression, and outcomes of familial hematological malignancies (FHM) through clinical evaluation, gene panel testing, and whole exome sequencing, highlighting the significance of identifying genetic causes for personalized treatment. Over six years, 357 patients initially diagnosed with bone marrow failure (BMF) were evaluated, with 152 patients lacking identifiable causes undergoing further analysis. Among these, 53 (34.9%) exhibited features of inherited BMF syndromes, and 13 (24.5%) developed FHM. In a separate cohort of 27 patients with inherited immunodeficiency disorders, 8 (29.6%) developed FHM associated with NHEJ1 or LYST variants, underscoring the familial clustering of hematologic disorders. Notably, 6 of 7 patients from the same family (family-1) with homozygous NHEJ1 variants progressed to secondary myelodysplastic syndrome (sMDS), acute myeloid leukemia (AML), or lymphoma. Among 780 patients diagnosed with hematological malignancies during the study period, 45 (5.8%) were confirmed to have FHM, with 33 patients enrolled for detailed analysis. Of these, 16 (48.5%) had DNA-repair deficiencies (DNA-RD), including eight with Fanconi anemia, six with NHEJ1 variants, and two with BRCA2 mutations. The remaining 17 patients presented conditions such as familial myeloproliferative neoplasms, dyskeratosis congenita (DC) [TERT, DKC1 variants], and Chediak-Higashi syndrome. Two siblings (family-3) with a rare TERT variant and a unique DC phenotype developed sMDS after prolonged BMF. Patients with DNA-RD were younger and exhibited higher rates of growth failure, recurrent infections, and endocrinopathies. These cases frequently progressed to sMDS or AML. A comparative analysis of 319 individuals with DNA double-strand break repair deficiencies revealed a 45% frequency of hematological malignancies. Lymphoma was most common in Nijmegen breakage syndrome (79.4%) while MDS/AML was prevalent in Cernunnos deficiency (66.6%). The findings emphasize the importance of early diagnosis, genetic testing, and personalized management, including timely transplantation, to improve outcomes in FHM. This research underscores the need for clinical awareness and surveillance to facilitate timely interventions and mitigate disease progression.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143565853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual presentation of age differences in relative survival of hematological neoplasms in Sweden and the neighboring countries.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-06 DOI: 10.1007/s00277-025-06291-4
Kari Hemminki, Frantisek Zitricky
{"title":"Visual presentation of age differences in relative survival of hematological neoplasms in Sweden and the neighboring countries.","authors":"Kari Hemminki, Frantisek Zitricky","doi":"10.1007/s00277-025-06291-4","DOIUrl":"https://doi.org/10.1007/s00277-025-06291-4","url":null,"abstract":"<p><p>For many hematological malignancies (HMs) survival among older patients is compromised. We want to test the most up-to-date age-group-specific survival differences in five hematological malignancies, Hodgkin lymphoma (HL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML) and myeloproliferative diseases (MPD) in Sweden (SE) and compared these to Denmark, Finland and Norway. For analysis we apply a recently published metric for comparing and visualizing age-group-specific relative survival differences using data from the NORDCAN database between 1972 and 2021. Periodic changes in age-related deviation in SE survival showed increasing differences for AML and MM while for the other HMs the differences declined in the course of time. Country-specific differences were observed, for Finnish male CLL and female MPD deviations were larger than those for the other countries, both of which were explained by the deviant survival of the oldest patients. Age-related deviations in 5-year survival increased for AML and MM for which survival improvements have been achieved through intense treatment regimens but these are not offered to old patients because of risk of complications. Paradoxically, improving overall survival in AML and MM has contributed to the widening of the age gaps. For the remaining HMs, age-related deviations declined with time as even old patients benefitted from the survival improvements; most notably female MPD and CLL patients had hardly any age gaps. Age disparities are an issue in hematological malignancies, and an intense search for novel treatments also includes old patients with an example of success as a novel drug venetoclax.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143565856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16-19, 2025.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-06 DOI: 10.1007/s00277-024-06139-3
{"title":"Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16-19, 2025.","authors":"","doi":"10.1007/s00277-024-06139-3","DOIUrl":"10.1007/s00277-024-06139-3","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143571878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sideroblastic anemia in children: challenges in diagnosis and management in three cases.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-05 DOI: 10.1007/s00277-025-06266-5
Samia Rekaya, Ilhem Ben Fraj, Rym Hamdi, Aicha Ben Taieb, Amani Merdassi, Hamida Jouini, Hajer Zarrouk, Ikram Zaiter, Ridha Kouki, Mohamed Bejaoui, Fethi Mellouli, Monia Ben Khaled, Monia Ouederni
{"title":"Sideroblastic anemia in children: challenges in diagnosis and management in three cases.","authors":"Samia Rekaya, Ilhem Ben Fraj, Rym Hamdi, Aicha Ben Taieb, Amani Merdassi, Hamida Jouini, Hajer Zarrouk, Ikram Zaiter, Ridha Kouki, Mohamed Bejaoui, Fethi Mellouli, Monia Ben Khaled, Monia Ouederni","doi":"10.1007/s00277-025-06266-5","DOIUrl":"https://doi.org/10.1007/s00277-025-06266-5","url":null,"abstract":"<p><p>Sideroblastic anemias (SAs) represent a heterogeneous group of rare hematological disorders characterized by iron accumulation in mitochondria of erythroblasts with ineffective erythropoiesis. SAs are categorized into acquired and congenital forms. Acquired, secondary, and clonal, SA is rare in pediatric populations. Congenital SA (CSA) is classified into syndromic and non-syndromic forms. Herein, we describe three cases of pediatric patients with SA. The diagnosis of SA was based on the presence of type 3 sideroblasts on BM aspirate smear (greater than 15%) and genetic tests. In the first case, the diagnosis of myelodysplastic syndrome with ring sideroblasts (MDS-RS) with somatic SF3B1 mutation was made at the age of 11 years. A whole exome sequencing did not reveal any germinal predisposition for MDS. A wait-and-see strategy was adopted. After one year- of follow-up, no blood transfusion was needed and no further cytopenia occurred. The two other children had presented anemia at an early age and were diagnosed with CSA. The first case was a girl with SCL25A38 gene mutation. For the second one, the diagnosis of aminolevulinic acid synthase 2 deficiency was considered the most plausible given the family history and the favourable response to pyridoxine. Iron overload occurred in both patients with CSA, requiring chelation therapy. In conclusion, Perls' stain remains a valuable tool for guiding the diagnosis of unexplained anemia in pediatric patients. Genetic testing is crucial for the characterization of congenital sideroblastic anemias. The incidence of myeloid neoplasms with ring sideroblasts is exceptional in children, and the long-term prognosis remains undefined.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143555436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the role of asthma in acute chest syndrome: a comparative analysis of patients with and without asthma.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-05 DOI: 10.1007/s00277-025-06233-0
Nehemias Guevara Rodriguez, Garry Franciss, Esmirna Perez, Zia Maryam
{"title":"Understanding the role of asthma in acute chest syndrome: a comparative analysis of patients with and without asthma.","authors":"Nehemias Guevara Rodriguez, Garry Franciss, Esmirna Perez, Zia Maryam","doi":"10.1007/s00277-025-06233-0","DOIUrl":"https://doi.org/10.1007/s00277-025-06233-0","url":null,"abstract":"&lt;p&gt;&lt;p&gt;While asthma is a known risk factor for Acute Chest Syndrome (ACS) and may increase overall mortality in SCD patients, this study specifically focuses on the rate of inpatient mortality, hospital stay, and costs in SCD patients who develop ACS. Our study was conducted using a retrospective cohort from the National Inpatient Sample (NIS), spanning 5 years from 2016 to 2020. Patients were carefully divided into two cohorts for comparison: those admitted with ACS and a history of asthma and those with ACS without a history of asthma. The primary endpoint was all-cause inpatient mortality, and we built a robust multivariate regression model adjusting for confounders. We also thoroughly examined secondary endpoints, including a comparison of length of stay (LOS), hospital, transfusion rates, mechanical ventilation (MV) rates, Continuous Renal Replacement Therapy (CRRT), and rates of hemodialysis (HD) for acute kidney injury (AKI). Our analysis of LOS and total cost was conducted using a multivariate linear regression model adjusted for confounders, ensuring the thoroughness and validity of our results. Additionally, genotypes, demographics, and common comorbidities were described. Categorical variables required Chi-square (X2), and continuous variables required a Student t-test for hypothesis testing. A two-tailed P-value of &lt; 0.05 was considered statistically significant. We utilized the National Inpatient Database (NIS). A total of 26,280 hospitalizations met the inclusion criteria:5,685 had ACS with a history of asthma, and 20,622 without ACS. Patients with ACS and Asthma were younger (mean age, 28 years vs. 32 years; p &lt; 0.001), and females represented a higher proportion (53.03% vs. 47.56%; p = 0.940). Patients admitted with ACS and Asthma did not have higher odds of dying than those admitted with ACS without asthma (p = 0.176). The Charlson Comorbidity Index (CCI) was the only predictor of mortality. (aOR 1.52; p &lt; 0.001). ACS with Asthma was a predictive factor for LOS (coefficient -0.65; p = 0.009). Conversely, female patients had a higher likelihood of experiencing a more extended hospital stay (coefficient, 0.61; p = 0.001). Additionally, ACS with Asthma significantly affected the total cost (coefficient: -15,201; p &lt; 0.001), resulting in a lower cost than ACS patients without asthma. Finally, patients with ACS with Asthma did not have higher rates of transfusions, MV, CRRT, or HD due to AKI than those without asthma. Asthma did not increase the risk of in-hospital mortality in this large retrospective cohort study of patients admitted for Acute Chest Syndrome (ACS). While patients with ACS and a history of asthma were younger and had a lower total cost of care, their length of stay was shorter, and they did not experience higher rates of transfusion, mechanical ventilation, or acute kidney injury requiring dialysis. The primary predictor of mortality was the Charlson Comorbidity Index (CCI), highlighting the importance of overall como","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143565855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tirabrutinib for CNS relapsed primary vitreoretinal lymphoma.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-04 DOI: 10.1007/s00277-025-06284-3
Nao Yoshida, Hiroshi Ureshino, Tomona Hiyama, Yosuke Harada, Suzuka Nakatani, Ren Chishaki, Taro Edahiro, Tetsumi Yoshida, Takero Shindo, Tatsuo Ichinohe
{"title":"Tirabrutinib for CNS relapsed primary vitreoretinal lymphoma.","authors":"Nao Yoshida, Hiroshi Ureshino, Tomona Hiyama, Yosuke Harada, Suzuka Nakatani, Ren Chishaki, Taro Edahiro, Tetsumi Yoshida, Takero Shindo, Tatsuo Ichinohe","doi":"10.1007/s00277-025-06284-3","DOIUrl":"https://doi.org/10.1007/s00277-025-06284-3","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143539749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting 30-day mortality in hemophagocytic lymphohistiocytosis: clinical features, biochemical parameters, and machine learning insights. 预测嗜血细胞淋巴组织细胞增多症的 30 天死亡率:临床特征、生化参数和机器学习见解。
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-01 DOI: 10.1007/s00277-025-06249-6
Jinli Zhu, Nengneng Cao, Fan Wu, Yangyang Ding, Xunyi Jiao, Jiajia Wang, Huiping Wang, Linhui Hu, Zhimin Zhai
{"title":"Predicting 30-day mortality in hemophagocytic lymphohistiocytosis: clinical features, biochemical parameters, and machine learning insights.","authors":"Jinli Zhu, Nengneng Cao, Fan Wu, Yangyang Ding, Xunyi Jiao, Jiajia Wang, Huiping Wang, Linhui Hu, Zhimin Zhai","doi":"10.1007/s00277-025-06249-6","DOIUrl":"https://doi.org/10.1007/s00277-025-06249-6","url":null,"abstract":"<p><p>This study aims to evaluate the clinical characteristics and biochemical parameters of hemophagocytic lymphohistiocytosis (HLH) patients to predict 30-day mortality. Parameters analyzed include lymphocyte count (L), platelet count (PLT), total protein (TP), albumin (ALB), blood urea nitrogen (BUN), and activated partial thromboplastin time (APTT). Machine learning (ML) approaches, including LASSO, random forest (RF), and support vector machine (SVM), were employed alongside meta-analysis and sensitivity analysis to validate the prognostic potential of these indicators. A retrospective analysis of 151 HLH patients was conducted to identify key predictive variables. Receiver operating characteristic (ROC) analysis, Kaplan-Meier (K-M) survival curves, and Cox regression analysis were used to evaluate the predictive capabilities of these parameters. ML algorithms determined optimal cut-off values to classify patients into high-risk and low-risk groups. A survival nomogram and risk scoring system were developed to provide individualized prognostic assessments. Meta-analysis aggregated data from existing literature to further validate differences in PLT, ALB, and APTT between deceased and surviving patients. Older age, low L, low PLT, low ALB, elevated BUN, and prolonged APTT were strongly associated with higher 30-day mortality risk in HLH patients. Six key indicators-TP, L, APTT, BUN, ALB, and PLT-were identified as critical predictors. ROC and K-M survival analyses highlighted the significance of these parameters. The survival nomogram and risk scoring system demonstrated high accuracy in predicting individualized mortality risk. Meta-analysis confirmed significant differences in PLT, ALB, and APTT between deceased and surviving patients, reinforcing the clinical value of these indicators. This study underscores the prognostic importance of specific clinical and biochemical parameters in predicting 30-day mortality in HLH patients. By integrating ML methodologies, a survival nomogram and risk scoring system were developed, offering valuable tools for early diagnosis, prognosis assessment, and personalized treatment planning in clinical practice.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143536439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas.
IF 3 3区 医学
Annals of Hematology Pub Date : 2025-03-01 DOI: 10.1007/s00277-025-06203-6
Juliette Dubois, Sarah Bellal, Marie-Christine Copin, Paul Mallet-Guy, Clément Bouron, Adrien Lannes, Aline Tanguy-Schmidt, Mathilde Hunault-Berger, Jérôme Paillassa
{"title":"Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas.","authors":"Juliette Dubois, Sarah Bellal, Marie-Christine Copin, Paul Mallet-Guy, Clément Bouron, Adrien Lannes, Aline Tanguy-Schmidt, Mathilde Hunault-Berger, Jérôme Paillassa","doi":"10.1007/s00277-025-06203-6","DOIUrl":"https://doi.org/10.1007/s00277-025-06203-6","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143536378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信